細(xì)胞研究
CELL RESEARCH
- 1001-0602
- 61
- 44.1
- Q1
- 1001-0602
- 61
- 44.1
- Q1
期刊簡介
細(xì)胞研究(CR)發(fā)表在生命科學(xué)所有領(lǐng)域具有不同尋常意義或廣泛概念或技術(shù)進(jìn)步的原創(chuàng)研究結(jié)果,只要該研究與分子和細(xì)胞生物學(xué)密切相關(guān)。該期刊具有國際作者身份,范圍廣泛,涵蓋基礎(chǔ)實(shí)驗(yàn)生物學(xué)和轉(zhuǎn)化研究。
Cell Research (CR) publishes original research results that are of unusual significance or broad conceptual or technical advances in all areas of life sciences, as long as the study is closely related to molecular and cell biology. The journal has an international authorship and a broad scope, covering both basic experimental biology and translational research.
-
Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans
引用量:110發(fā)表時間:2024年
-
Structural basis for human Cav3.2 inhibition by selective antagonists
引用量:70發(fā)表時間:2024年
-
Structural insights into human exon-defined spliceosome prior to activation
引用量:59發(fā)表時間:2024年
-
APOE3challeviates Aβ and tau pathology and neurodegeneration in the human APPNL-G-Fcerebral organoid model of Alzheimer’s disease
引用量:15發(fā)表時間:2024年
-
Structural basis for different ω-agatoxin IVA sensitivities of the P-type and Q-type Cav2.1 channels
引用量:14發(fā)表時間:2024年
-
ATP6AP1 wasPhast-ID’ed as a long-sought GEF for Rheb
引用量:12發(fā)表時間:2024年
-
A tale of two calcium channels: structural pharmacology of Cav2.1 and Cav3.2
引用量:12發(fā)表時間:2024年
-
Cytolytic too: Granzyme B-expressing human ILC2s mediate tumor rejection
引用量:10發(fā)表時間:2024年
-
The hidden face of GluD1 at inhibitory synapses
引用量:10發(fā)表時間:2024年
-
Decoding T cell state-specific regulomes in cancer
引用量:10發(fā)表時間:2024年